Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report

Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report

The study objective is to report a case of successful treatment of disseminated nasopharyngeal carcinoma with nivolumab.Materials and methods. A 22-year-old male patient was admitted to N.N. Blokhin National Medical Research Center of Oncology with a diagnosis of T3N3M1 stage IV nasopharyngeal carci...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. M. Bychkov, A. M. Mudunov, I. M. Gelfand, B. G. Pkheshkhova, O. D. Ryzhova, А. A. Akhundov, V. Z. Dobrokhotova, М. N. Narimanov
Format:	Article
Language:	Russian
Published:	ABV-press 2019-07-01
Series:	Опухоли головы и шеи
Subjects:	nasopharyngeal carcinoma metastases chemotherapy nivolumab
Online Access:	https://ogsh.abvpress.ru/jour/article/view/411
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of camrelizumab in treatment of nasopharyngeal carcinoma
by: Yu. V. Alymov, et al.
Published: (2024-12-01)

Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab
by: Tsutomu Namikawa, et al.
Published: (2018-07-01)

Bullous pemphigoid associated with the use of nivolumab in a patient with metastatic melanoma: a case report.
by: Diego Lopes Paim Miranda, et al.
Published: (2020-01-01)

Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab
by: Toshihiko Matsumoto, et al.
Published: (2025-08-01)

18F-fluorodeoxyglucose-positron emission tomography/computed tomography imaging of metastatic nasopharyngeal cancer with emphasis on the distribution of bone metastases
by: Ammad Al Tamimi, et al.
Published: (2017-07-01)

Combination of concurrent targeted and immune-therapy with nivolumab and cetuximab: new perspectives for squamous cell carcinoma treatment
by: A. M. Mudunov, et al.
Published: (2020-11-01)

A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma
by: K. I. Utesheva, et al.
Published: (2023-03-01)

Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation
by: N. N. Babyshkina, et al.
Published: (2022-11-01)

Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma
by: Valerie Glutsch, et al.
Published: (2024-12-01)

Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
by: A. M. Mudunov, et al.
Published: (2019-04-01)

Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
by: Amparo Burgos-San José, et al.
Published: (2021-05-01)

NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
by: A. M. Mudunov, et al.
Published: (2017-06-01)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
by: Han Zhou, et al.
Published: (2020-04-01)

Nivolumab-induced interstitial lung disease in the patient with melanoma
by: Marcin Morawski, et al.
Published: (2024-02-01)

Nasopharyngeal carcinoma in a 15-year-old: A rare pediatric tumor
by: Safina Zahir Msangi, MD, et al.
Published: (2025-09-01)

Combined Use of Cabozantinib and Nivolumab in Clinical Practice
by: V. E. Askarov, et al.
Published: (2024-04-01)

Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring
by: Heng Jiao, et al.
Published: (2025-05-01)

NIVOLUMAB IN THE TREATMENT OF REFRACTORY RECURRENT AND METАSTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA. THE RESULTS OF A PHASE III CLINICAL TRIAL (CHECKMATE 141)
by: A. M. Mudunov
Published: (2017-11-01)

Successful treatment for disseminated nasopharyngeal cancer with bone marrow metastases: a clinical case
by: Z. A. Radzhabova, et al.
Published: (2015-11-01)

Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
by: Kun-Peng Wu, et al.
Published: (2025-12-01)

Familial clustering of nasopharyngeal carcinoma in the family of an adolescent with nasopharyngeal carcinoma
by: Buket Kara, et al.
Published: (2022-12-01)

A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
by: Anna Spreafico, et al.
Published: (2025-01-01)

Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report
by: Shunji Endo, et al.
Published: (2020-10-01)

Multimodal management of solitary axillary lymph node metastasis from a recurrent nasopharyngeal undifferentiated carcinoma: a case report and review of the literature
by: Houyem Mansouri, et al.
Published: (2025-06-01)

Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma
by: Omer Faruk Kuzu, et al.
Published: (2025-07-01)

Metastatic nasopharyngeal carcinoma: Outcome from Cancer Institute, Chennai
by: Arun Kumar, et al.
Published: (2020-01-01)

Colitis grave inmunomediada por Nivolumab-Ipilimumab: a propósito de un caso
by: Maria Victoria Foglino, et al.
Published: (2025-07-01)

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?
by: Birol Ocak, et al.
Published: (2024-09-01)

Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
by: Lin-Feng Guo, et al.
Published: (2025-08-01)

Deep learning-based multi-omics model to predict nasopharyngeal necrosis of re-irradiation for recurrent nasopharyngeal carcinoma
by: Xingwang Gao, et al.
Published: (2025-07-01)

Organ preservation treatment of locally advanced cancer of the laryngopharynx using regional intra-arterial chemotherapy in a patient with solitary kidney
by: A. A. Akhundov, et al.
Published: (2019-04-01)

Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma
by: Rui-Ling Xie, et al.
Published: (2025-04-01)

Nivolumab in two cases of refractory mycosis fungoides erythroderma
by: Ewa Chmielowska
Published: (2021-12-01)

Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan
by: Tomoki Taniguchi, et al.
Published: (2024-12-01)

Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review
by: D. D. Ivanova, et al.
Published: (2024-12-01)

Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer
by: Chen Jun, et al.
Published: (2023-05-01)

Prediction of induction chemotherapy response in locoregionally advanced nasopharyngeal carcinoma based on three pretreatment non-Gaussian diffusion MRI models
by: Huanhuan Ren, et al.
Published: (2025-07-01)

A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus
by: Keita Hanada, et al.
Published: (2022-11-01)

Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
by: Koji Yasuda, et al.
Published: (2017-08-01)

Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study
by: Toshiyuki Sumi, et al.
Published: (2025-01-01)